The high cost of the brand name drugs and lack of insurance coverage has led to "these sort of gray markets that are cropping up all over the place that are forcing patients to make these trade-offs," Dr
Side effects are typically mild and manageable
Other GLP-1 Medications Involved in Litigation The federal multidistrict litigation consolidated as MDL 3094 encompasses multiple GLP-1 receptor agonist medications beyond just Ozempic, reflecting the class-wide nature of the alleged injuries and inadequate warnings
We do not yet have evidence that they're safe for people without obesity, diabetes, and/or cardiometabolic disease
Dehydration symptoms typically worsen throughout the day if fluids arent replenished, whilst medication side effects often follow a pattern related to injection timing
Almost certainly, yes, you will gain back some of the weight you lost